See other bills
under the
same topic
                                                       PRINTER'S NO. 212

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 186 Session of 2007


        INTRODUCED BY SOLOBAY, CALTAGIRONE, CAPPELLI, CARROLL, COHEN,
           COX, DALEY, J. EVANS, FABRIZIO, FRANKEL, GALLOWAY, GEIST,
           GEORGE, GIBBONS, GINGRICH, GOODMAN, GRUCELA, HENNESSEY,
           HERSHEY, HESS, HORNAMAN, JAMES, KOTIK, KULA, MAHONEY, MANN,
           MELIO, MILLARD, MOYER, MUNDY, M. O'BRIEN, PALLONE, PETRARCA,
           PETRONE, REICHLEY, SABATINA, SAINATO, STABACK, SURRA, VEREB,
           WALKO, WOJNAROSKI AND YOUNGBLOOD, FEBRUARY 1, 2007

        REFERRED TO COMMITTEE ON HEALTH AND HUMAN SERVICES,
           FEBRUARY 1, 2007

                                     AN ACT

     1  Establishing the Cancer Drug Repository Program for accepting
     2     donated cancer drugs and dispensing cancer drugs.

     3     The General Assembly of the Commonwealth of Pennsylvania
     4  hereby enacts as follows:
     5  Section 1.  Short title.
     6     This act shall be known and may be cited as the Cancer Drug
     7  Repository Program Act.
     8  Section 2.  Definitions.
     9     The following words and phrases when used in this act shall
    10  have the meanings given to them in this section unless the
    11  context clearly indicates otherwise:
    12     "Board."  The State Board of Pharmacy.
    13     "Cancer drug."  A prescription drug used to treat any of the
    14  following:
    15         (1)  Cancer or its side effects.

     1         (2)  The side effects of a prescription drug used to
     2     treat cancer or its side effects.
     3     "Health care facility."  A for-profit or nonprofit entity
     4  providing clinically related health services, including those
     5  operated by the Commonwealth or its political subdivisions and
     6  including a general or special hospital, including psychiatric
     7  hospitals, rehabilitation hospitals, ambulatory surgical
     8  facilities, long-term care nursing facilities, a hospice, cancer
     9  treatment center using radiation therapy on an ambulatory basis
    10  and inpatient drug and alcohol treatment facility.
    11     "Health clinic."  A for-profit or nonprofit clinic providing
    12  health services.
    13     "Hospital."  An entity licensed as a hospital under:
    14         (1)  the act of June 13, 1967 (P.L.31, No.21), known as
    15     the Public Welfare Code; or
    16         (2)  the act of July 19, 1979 (P.L.130, No.48), known as
    17     the Health Care Facilities Act.
    18     "Pharmacy."  A pharmacy licensed by the Commonwealth.
    19     "Physician's office."  The office of a person licensed to
    20  practice medicine and surgery or osteopathic medicine and
    21  surgery.
    22     "Prescribing practitioner."  A health care practitioner
    23  licensed under the laws of this Commonwealth who is authorized
    24  to prescribe cancer drugs.
    25     "Prescription drug."  All drugs requiring a prescription in
    26  this Commonwealth.
    27     "Program."  The Cancer Drug Repository Program established in
    28  section 3.
    29  Section 3.  Establishment.
    30     The board shall establish a Cancer Drug Repository Program
    20070H0186B0212                  - 2 -     

     1  for accepting donated cancer drugs and dispensing cancer drugs
     2  to residents of this Commonwealth. Participation in the program
     3  shall be voluntary.
     4  Section 4.  Donation of cancer drugs.
     5     Any person or entity, including, but not limited to, a cancer
     6  drug manufacturer or health care facility, may donate cancer
     7  drugs to the program. Cancer drugs may be donated at a
     8  physician's office, pharmacy, hospital or health clinic that
     9  elects to participate in the program and meets the criteria
    10  established by the board for participation.
    11  Section 5.  Acceptance and dispensation of cancer drugs.
    12         (1)  A cancer drug shall only be accepted or dispensed
    13     under the program if the drug is in its original unopened,
    14     sealed and tamper-evident unit dose packaging. A cancer drug
    15     packaged in single-unit doses may be accepted and dispensed
    16     if the outside packaging is opened but the single-unit-dose
    17     packaging is unopened.
    18         (2)  A cancer drug shall not be accepted or dispensed
    19     under the program if the drug bears an expiration date that
    20     is earlier than six months after the date the drug was
    21     donated or the drug is adulterated or misbranded.
    22         (3)  Except as provided in this subsection, unused cancer
    23     drugs dispensed under a State medical assistance program may
    24     be accepted and dispensed under the program.
    25  Section 6.  Storage, distribution and fees.
    26         (1)  A physician's office, pharmacy, hospital or health
    27     clinic that accepts donated cancer drugs under the program
    28     shall comply with all applicable provisions of Federal and
    29     State law relating to the storage, distribution and
    30     dispensing of cancer drugs and shall inspect all cancer drugs
    20070H0186B0212                  - 3 -     

     1     prior to dispensing to determine if they are adulterated or
     2     misbranded. The drugs shall only be dispensed pursuant to a
     3     prescription issued by a prescribing practitioner. The drugs
     4     may be distributed to another participating physician's
     5     office, pharmacy, hospital or health clinic for dispensing.
     6         (2)  A physician's office, pharmacy, hospital or health
     7     clinic may charge a handling fee for distributing or
     8     dispensing cancer drugs under the program. The fee shall be
     9     established in regulations promulgated by the board. Cancer
    10     drugs donated under the program shall not be resold.
    11  Section 7.  Immunity.
    12         (1)  Any person or entity, including a cancer drug
    13     manufacturer, which exercises reasonable care in donating,
    14     accepting, distributing or dispensing cancer drugs under the
    15     program shall be immune from civil or criminal liability or
    16     professional disciplinary action for any injury, death or
    17     loss to a person or property relating to such activities.
    18         (2)  Notwithstanding paragraph (1), the donation of a
    19     cancer drug by a cancer drug manufacturer shall not:
    20             (i)  Absolve the manufacturer of any criminal or
    21         civil liability that would have existed except for the
    22         donation.
    23             (ii)  Increase the liability of the cancer drug
    24         manufacturer that would have existed except for the
    25         donation.
    26  Section 8.  Regulations.
    27     The board shall promulgate regulations to carry out the
    28  purposes of this act within 90 days of the effective date of
    29  this act. The regulations shall include:
    30         (1)  Eligibility criteria and other standards and
    20070H0186B0212                  - 4 -     

     1     procedures for physician's offices, pharmacies, pharmacists,
     2     hospitals and health clinics that accept and distribute or
     3     dispense donated cancer drugs.
     4         (2)  Necessary forms for administration of the program,
     5     including forms for use by persons or entities that donate
     6     cancer drugs under the program.
     7         (3)  The maximum handling fee that may be charged by
     8     physician's offices, pharmacies, hospitals or health clinics
     9     that accept and distribute or dispense donated cancer drugs.
    10         (4)  Categories of cancer drugs that the program will
    11     accept for dispensing and categories of cancer drugs that the
    12     program will not accept for dispensing and the reason that
    13     the drugs will not be accepted.
    14  Section 25.  Effective date.
    15     This act shall take effect in 60 days.










    L20L35JS/20070H0186B0212         - 5 -